+ All Categories
Home > Documents > PARAPNEUMONIC SYNDROME.ppt

PARAPNEUMONIC SYNDROME.ppt

Date post: 17-Oct-2015
Category:
Upload: saga-sabara
View: 39 times
Download: 0 times
Share this document with a friend
Popular Tags:

of 28

Transcript
  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    1/28

    PARAPNEUMONIC SYNDROME(Laporan Kasus)

    Arismunandar H.P.U

    0818011008

    1

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    2/28

    Identitas Pasien

    Nama : Tn. S Umur : 60 tahun

    Jenis Kelamin : Laki-laki

    Pekerjaan : Petani

    Agama : Islam

    Alamat : Punggur

    Tanggal Masuk : 19 Januari 2013, pukul 18.00WIB

    2

    1. ANAMNESIS

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    3/28

    Keluhan Utama

    Buang air besar cair sejak 1 hari SMRS

    Keluhan Tambahan

    Demam,batuk berdahak, pilek, sesak

    3

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    4/28

    Riwayat Penyakit Sekarang

    Pasien datang ke IGD RSAY Metro dengan keluhan buang airbesar cair sejak 1 hari SMRS. Buang air besar sebanyak 5 kalidengan konsistensi cair, ampas yang sedikit dan berlendir tanpadisertai darah. Pasien juga mengeluh demam yang naik turunsejak 2 hari SMRS dan disertai dengan pilek dan batuk berdahak,dahak berwarna hijau tanpa disertai darah. Pasien juga

    mengeluh sesak nafas dan dada terasa berat sejak 2 hari SMRS.Sesak nafas timbul saat istirahat dan tidak diperberat olehaktivitas. Pasien juga mengaku tidak nafsu makan dan badanterasa lemas. Karena khawatir akan kondisi dirinya, maka pasiendatang ke IGD RSAY Metro untuk berobat.

    4

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    5/28

    Riwayat Penyakit Dahulu

    Riwayat kencing manis

    : disangkal Riwayat darah tinggi

    : disangkal

    Riwayat sakit jantung

    : disangkal

    Riwayat minum OAT :disangkal

    Pasien belum pernahmengalami sakit seperti inisebelumnya

    5

    RiwayatPenyakitKeluarga

    Riwayat penyakit serupa: disangkal

    Riwayat darah tinggi :disangkal

    Riwayat kencing manis : disangkal

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    6/28

    PEMERIKSAAN FISIK

    Keadaan Umum : sakit berat, compos mentis,

    gizi kurang (berat badan 45 kg,tinggi badan 1,67 m, BMI = 16,1)

    Tanda Vital

    Tekanan darah : 60/40 mmHg Nadi : 124 x/menit , cepat dan lemah

    Pernapasan : 40 x/menit

    Suhu : 38,7 C

    Saturasi O2 : 90 %

    6

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    7/28

    Kepala : normochepal, simetris.

    Mata : Conjungtiva anemis (-/-), sclera ikterik (-/-) Pupil isokor (3 mm/3mm), Reflek cahaya (+/+).

    Hidung : Nafas cuping hidung (+), darah (-), secret (-).

    Telinga : darah (-), secret (-).

    Mulut : mukosa basah (+), sianosis (-), lidah kotor (-).

    Leher : Simetris, limfonodi coli tidak membesar. Thorax : retraksi intercostal (+)

    7

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    8/28

    Jantung

    Inspeksi : ictus cordis tidak tampak

    Palpasi : ictus cordis tidak teraba

    Perkusi : batas jantung dalam batasnormal

    Auskultasi : BJ I-II intensitas normal,reguler, murmur (-), gallop (-)

    Paru Inspeksi : Saat statis bagian dada kanan sama dengan

    bagian kiri, saat dinamis, gerakan dada kanantertinggal dari kiri. Retraksi intercostal, dansubcostal ditemukan

    Palpasi : Fremitus taktil kanan lebih lemah dari kiri Perkusi : pekak/sonor

    Auskultasi : ronki +/-, wheezing -/-

    8

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    9/28

    Abdomen

    Inspeksi : tampak datar, dinding

    perut sejajar dengan dinding dada Auskultasi : bising usus (+)

    Perkusi : Tympani

    Palpasi : Supel, nyeri tekan (-), hepar/lien

    tidak teraba Trunk

    Inspeksi : Skoliosis (-), kifosis (-), lordosis (-)

    Palpasi : Nyeri tekan (-), massa (-)

    Perkusi : Nyeri ketok (-)

    Ekstremitas :Oedem -/- Akral dingin -/-

    9

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    10/28

    PEMERIKSAAN PENUNJANG

    Laboratorium (19 Januari 2013) :

    DL :Hb : 9,5 g/dL

    WBC : 34.600 /ul

    RBC : 4,46 juta /ul

    PLT : 437.000 /ul

    GDS : 94 mg/dL

    Ureum : 66,2 mg/dL

    Kreatinin : 2,02 mg/dL

    SGOT : 69,8 U/L

    SGPT : 33,4 U/L

    Albumin : 2,7 g/dL

    Globulin : 1,74 g/dL

    10

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    11/28

    UL : leukosit 10/ul, eritrosit 30/uL, epitel ++

    Feses lengkap :

    macros : konsistensi lembek, lendir,darah negatif

    micros : leukosit, eritrosit negatif

    BTA sputum S-P-S : negatif-negatif-negatif

    Kultur darah (22-1-2013) : hasil steril

    11

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    12/28

    Foto Rontgen Thorax PA (23 Januari 2013) :

    12

    Kesan: Efusi pleura dextra

    bronkopneumonia

    kardiomegalidengan elongatioaorta

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    13/28

    USG Abdomen (21 Januari 2013) :

    Complex pleural effusion supradiafragma dextra

    Pielonefritis sinistra

    Hepar,, lien, pancreas, vesica urinaria dalam batas normal

    Dilakukan pungsi pleura pada tanggal 19 januari 2013, kemudian dilakukan analisadan sitologi cairan pleura, hasil :

    Analisa cairan pleura (21-1-2013) :

    Protein total serum : 5,76 g/dL, ratio 0,8

    LDH serum : 291 U/L, ratio 3,2

    Glukosa : 72 mg/dL

    Pewarnaan BTA : negatif, pewarnaan gram : kokus gram positif

    Sifat cairan pleura adalah eksudat dengan infeksi sekunder oleh kuman kokusgram positif.

    Patologi anatomi cairan pleura (24-1-2013) :

    Sel malignancy negative

    Peradangan kronis supuratif (abses)

    13

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    14/28

    Diagnosa kerja:1.Pneumonia dengan efusi pleura dextra

    (parapneumonic syndrome) 2. Syok sepsis

    2.Diarrhea3. Malnutrisi underweight

    5. PENATALAKSANAAN O2 2L/mnt IVFD RL guyur 1 liter maintenance 40 tetes/menit Levofloxacin 1 x 750 mg i.v

    Ceftriaxone 2 x gr i.v Metronidazol 3 x 500 mg i.v Ranitidine 2 x 1 amp i.v Metoclopramid 2 x 1 amp i.v Diet : TKTP Nasi + ekstra telur 6. PROGNOSIS Ad vitam : dubia Ad sanam : dubia Ad fungsionam : dubia

    14

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    15/28

    15

    PARAPNEUMONIC SYNDROME

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    16/28

    Parapneumonic syndrome : Pneumonia symptoms with parapneumonic effusion

    (exudative pleural effusion) that results frompneumonia (CAP/NP) or lung abses

    Between 20% and 57% of the 1 million patientshospitalized yearly in the U.S with pneumonia,develop a PPE.

    Empyema is less common, occurring

    in 5%

    10% of patients who experience PPE

    16

    INTRODUCTION

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    17/28

    Figure 1. Causes of empyema in 14 prior studies. Of the 1383 patients inthe studies, 70% were parapneumonic. For the other 30% of patients,trauma was the cause of empyema in 7%, empyema was postoperativein 6%, and prior tuberculosis was the cause in 4%; 12% of cases weredue to other causes.

    17

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    18/28

    Clinical classificationof PPE :

    1. uncomplicated parapneumonic effusion (UPPE) 2. complicated parapneumonic effusion (CPPE)

    3. Empyema

    Stages : 1. exudative

    2. fibrinopurulent

    3. final organizational

    18

    CLASSIFICATION

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    19/28

    Symptoms of pneumonia :

    Fever, malaise, cough, dyspnea, pleuritic chest pain

    Eldery patients >> asymptomatic

    19

    CLINICAL PRESENTATION

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    20/28

    Pleural fluid analysis >>> to stage the PPE and guidesinitial management.

    UPPEs : have a turbid appearance, with a pH >7.30, aglucose level >60 mg/dL, an LDH level

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    21/28

    21

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    22/28

    recommended that all patients withpneumonia be evaluated for the

    presence of pleural fluid.

    With the possible or definite presence ofpleural fluid noted on a chest

    radiograph, an ultrasound-guidedthoracentesis should be performed.

    Ultrasonography can detect stranding or

    septation in the fluid suggestive of aCPPE and can facilitate its drainage.

    22

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    23/28

    Figure 3. A complex, septate pleural effusion demonstrated byultrasonography in a patient with spontaneous hemorrhageinto a pre-existing pleural effusion. This precise pattern is

    typical of a complicated parapneumoniceffusion as well.

    23

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    24/28

    Figure 2. The estimated time course ofuntreated or inappropriately treatedparapneumonic effusions. In general, anempyema will develop 46 weeks after

    the onset of aspiration of bacteria into thelung.24

    PATHOPHYSIOLOGY

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    25/28

    In general, early and appropriate antibiotic treatmentwill prevent the development of a PPE and itsprogression.

    25

    MANAGEMENT

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    26/28

    Antibiotic therapy : Early antibiotic therapy will prevent the development of aPPE and its progression to a CPPE and empyema.

    Pleural space drainage :

    Clinical factors that suggest pleural space drainage include :

    prolonged pneumonia symptoms,

    Comorbid disease,

    failure to respond to antibiotic therapy, and

    presence of anaerobic organisms .

    Chest radiograph findings that suggest the need for pleural space drainageinclude an effusion involving >50% of the hemothorax

    Stranding or septation noted on an ultrasound suggests the need for pleuralspace drainage.

    Intrapleural fibrinolytics : fibrinolytic agents (urokinase and tissue plasminogenactivator) most effective in the early fibrinolytic stage in avoiding the need forsurgical drainage.

    Surgery : pleural space drainage by tube thoracostomy has been ineffective incontrolling the pleural infection. (VATS).

    26

    MANAGEMENT

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    27/28

    1. Early antibiotic treatment usually prevents the development of a PPE and its progressionto a complicated PPE and empyema.

    2. Pleural fluid analysis provides diagnostic information and guides therapy.

    3. If the PPE is small to moderate in size, free-flowing, and nonpurulent (pH, >7.30), it ishighly likely that antibiotic treatment alone will be effective.

    4. Prolonged pneumonia symptoms before evaluation, pleural fluid with a pH

  • 5/26/2018 PARAPNEUMONIC SYNDROME.ppt

    28/28

    28

    TERIMA KASIH


Recommended